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Nucleotide bindinge binding afﬁnity of NADH, NAD+, and their analogues for complex I as emerged
from the steady-state kinetics data and from more direct studies under equilibrium conditions are
summarized and discussed. The redox-dependency of the nucleotide binding and the reductant-induced
change of FMN afﬁnity to its tight non-covalent binding site indicate that binding (dissociation) of the
substrate (product) may energetically contribute to the proton-translocating activity of complex I.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Mitochondrial NADH:ubiquinone oxidoreductase (complex I) and
its prokaryotic homologues (NDH-1) are intrinsic components of the
respiratory chains that catalyze the ﬁrst step of intramitochondrial or
intracellular NADH oxidation (or NAD+ reduction) and vectorial
translocation of protons across the coupling membrane. Under
boptimal” conditions (uncoupled NADH oxidase activity of inside-out
bovine heart submitochondrial particles (SMP) at saturating NADH
concentration, pH 8.0, 25 °C) the enzyme turnover is about 150 s−1 [1].
Approximately the same rotenone-sensitive steady-state turnover is
seen with exogenous ubiquinone homologue, Q1, as electron acceptor.
The multiple iron–sulfur clusters [2] participating in intramolecular
electron transfer from FMN, presumably the primary oxidant (reduc-
tant) of NADH (NAD+), are almost completely reduced during the
steady-state NADH-supported coupled or uncoupled respiration [3,4].
Reoxidation of the terminal iron–sulfur cluster N-2 thus seems to be
the rate-limiting step of the overall NADH oxidase or NADH:
ubiquinone reductase \reactions. The enzyme turnover in the
rotenone-insensitive “diaphorase” activities of complex I as revealed
with a number of artiﬁcial electron acceptors such as ferricyanide,
hexaammineruthenium (III) (HAR), DCIP, menadione, cytochrome c,enine dinucleotide; DCIP, 2,6-
P, 2–3 subunit soluble fragment
prokaryotic homologue of the
x I); pmf, proton-motive force,
ethyl-6-[3-methyl-2-butenyl]-
nated according to Ohnishi's
l rights reserved.acetyl-NAD+ (transhydrogenase reaction), oxygen (generation of
superoxide radical) varies from less than 0.1 (superoxide generation)
to 1000% of that measured in the natural NADH oxidase reaction [1].
NADH oxidation by ubiquinone is energetically coupled with
translocation of 4 protons per pair of electrons transferred [5–7].
This stoichiometry eliminates the single Mitchellian redox loop [8] as
the onlymechanism of pmf generation in theNADH:ubiquinone region
of the respiratory chain. Other possibilities such as energy-coupled
redox-dependent substrate/product binding/release conformational
change mechanism are worthy of consideration besides a number of
hypothetical models that have been proposed for a direct redox-
coupled proton-translocating loop mechanism at the N-2–ubiquinone
junction site [9–16]. In fact, the NADH-induced conformational change
of complex I has been qualitatively demonstrated [17–19]. To create
any testable model for the conformationally-driven energy transduc-
tionmodel quantitative informationon the parameters of the substrate
(product) binding (release) is needed. Here the current state of
knowledge of NADH, NAD+, and their analogues interactionwith com-
plex I as related to the ﬂavin redox state is brieﬂy summarized and
discussed.
2. NADH/NAD+ binding afﬁnities as emerged from the
steady-state kinetics
Numerous reports have been published on NADH/NAD+ afﬁnities
to complex I or to other enzymatically active preparations derived
from the intact complex. These reports have used different approaches
including the steady-state kinetics. Here only the data on the
membrane-bound and puriﬁed dispersed complex I or so-called
“high molecular weight” NADH dehydrogenase are discussed. The
redox potentials of the iron–sulfur centers [20] and likely FMN are
Table 1























SNDH, 30 °C, pH 7.8 Ferricyanide reductase 100 21
BHC-I, 25 °C, pH 7.5 Ferricyanide reductase Ping-pong 100 50 22
B-SMP, 27 °C, pH 8.0 HAR reductase Ordered N40b (100) No inhibition 23
B-SMP, 30 °C, pH 8.0 Oxidase 2 1 000; 1 600 No inhibition 7; 25 40; 80 24, 25
P-SBP, 25 °C, pH 7.0 Oxidase 5 No inhibition 20 26
P-SBP, 25 °C, pH 8.0 Oxidase 7 270 27
BHC-I, 20 °C, pH 8.0 Q1 reductase Ordered,
ternary complex
2 No inhibition 28
BHC-I, 32 °C, pH 7.5 Acetyl-NAD+
transhydrogenase
Ping-pong 100 160–260 29
HAR reductase 90 29
Superoxide generation 0.05c Strong inhibition 30
a Abbreviations: SNDH, soluble highmolecular weight NADH dehydrogenase derived from bovine heart submitochondrial particles; BHC-I, puriﬁed bovine heart complex I; B-SMP,
bovine heart inside-out submitochondrial particles; P-SBP, inside-out plasma membrane vesicles from anaerobically grown P. denitriﬁcans.
b At 0.5 mM HAR. Signiﬁcantly higher KmNADH (100 μM) is seen at high (2 mM) concentration of HAR.
с Only 5-times molar excess of NADH over the enzyme concentration in the presence of NADH-regenerating system.
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complex I (such as FP, ﬂavoprotein fragment of complex I. Although FP
certainly bears the NADH binding site, these redox modiﬁcations are
expected to modify also the apparent afﬁnities to NADH/NAD+ (see
below). Before discussing quantitative data summarized in Table 1,
some comments on the steady-state kinetics of NADH oxidation seem
to be helpful.
The simplest (single NADH binding site and single site for the
enzyme reoxidation) scheme describing NADH oxidation catalyzed by
complex I is depicted in Fig. 1. Because two substrates (NADH and
electron acceptor) are involved at least two alternative reaction
pathways are conceivable: after NADH binding and intramolecular
oxidoreduction (intermediates 1, 2, and 3) an electron acceptor may
oxidize the enzyme before dissociation of NAD+ (the overall reaction
proceeds via intermediates 1, 2, 3, and 4); alternatively, an electron
acceptor may reoxidize product-free reduced enzyme only (inter-
mediates 1, 2, 3, and 5). According to text-book steady-state kinetics
the ﬁrst alternative is characterized by a series of simple hyperbolic
initial rate versus NADH concentration dependencies with different
apparent KmNADH values, which are extrapolated to KSNADH when
electron acceptor concentration is extrapolated to zero. For redox
enzymes the KSNADH value thus obtained is not a measure of primary
NADH binding to the active site (K1, Fig. 1) but it is always a product,
K1·K2, where K2 is the redox equilibrium constant for the intramo-Fig. 1. Simpliﬁed scheme describing the steady-state NADH oxidation and NAD+ reduction b
text for further explanation).lecular electron transfer between bound NADH and primary enzyme-
bound electron acceptor, presumably FMN. The alternative mechan-
ism (reoxidation of product-free reduced enzyme, intermediates 1, 2,
3, and 5) gives a series of parallel lines in 1/v versus 1/[NADH] graphs
at different acceptor concentrations with apparent KmNADH extrapolat-
ing to zero when an electron acceptor concentration extrapolates to
zero (ping-pong mechanism). It should be noted that if K2 bb1, i.e. the
intramolecular oxidoreduction is greatly shifted to the intermediate 3
(e.g. midpoint redox potential of FMN/FMNH2 is signiﬁcantly more
positive than that of bound NADH/NAD+), two alternative mechanisms
become kinetically undistinguishable. Indeed, if so, the interconver-
sion 2→3 becomes “irreversible” just like interconversion 3→5 is in
the ping-pong mechanism where “irreversibility” is due to the initial
rate limitation ([NAD+]=0). It is also possible that the reaction
proceeds both via 1, 2, 3, 4, and 1, 2, 3, 5 intermediates with relative
contributions of two pathways that depend on particular electron
acceptor concentration. In this case deviations from simple hyperbolic
rate-reactant concentrations dependencies are expected.
2.1. Binding of NADH
The apparent KmNADH values published in the literature for the
reactions with different electron acceptors (Table 1) can, at ﬁrst
approximation, be divided into “highKm” (rotenone-insensitive artiﬁcialy complex I. Shadowed numbered circles are designation for distinct intermediates (see
731A.D. Vinogradov / Biochimica et Biophysica Acta 1777 (2008) 729–734acceptor reductases) and “low Km” (rotenone-sensitive quinone reduc-
tases) activities. The difference between apparentKmNADH in these groups
are evidently too large (about 50 times) to be accounted for slight
variations in pH, temperature and assay buffer composition. Rather, it is
related to different species designated as Ered in the reaction pathway in
Fig. 1. Complex I is a multiple redox component enzyme and since
ferricyanide [31] and HAR [32] are efﬁcient electron acceptors for FP it is
safe to assume that they reoxidize ﬂavin, the primary electron acceptor
for bound NADH. The Ered species potentially reactive with these
acceptors in 1, 2, 3, 4 pathway is NAD+·E·Flred, and apparent KmNADH is, as
noted above, equal to K1·K2, where K2 is the equilibrium constant for
bound NADH-FMN oxidoreduction. When the enzyme is reoxidized by
quinone (rotenone-sensitive reaction) the corresponding Ered specie is
NAD+·E·(N-2)red and a series of electron transfer steps from FMNH2 to
iron–sulfur cluster N-2 contribute toK2. Because themidpoint potential
of N-2 is much more positive than that of ﬂavin (at least 200 mV
difference [33,34]) K2 is bb1 and low KmNADH values are related to
thermodynamics of intramolecular electron transfer, not to the true
afﬁnity of NADH to its binding site. Therefore, true afﬁnity of NADH to
the oxidized enzyme (K1, Fig. 1) is less or equal to ~10−4 M.
It was noted many years ago that the reaction with ferricyanide is
strongly inhibited by NADH [21,22]. NADH-supported and succinate-
supported superoxide generation [35], as well as, NADH:Acetyl-NAD+
transhydrogenase activity [29] are also strongly inhibited by NADH.
This inhibition was interpreted as evidence for the ping-pong
mechanismwith double substrate inhibition [22]. The recently solved
atomic structure of the hydrophilic fragment of NDH-1 from Thermus
thermophilus [36] agrees with the earlier proposal that ferricyanide
reoxidizes NAD+-free reduced enzyme only: the reactive component
(FMN) in the enzyme from this species is located in a deep cleft being
accessible for either negatively charged hydrophilic ferricyanide (-3)
or negatively charged hydrophilic NADH (-2), not for both. However,
no inhibition by NADH is seen in the NADH:HAR reductase activities
catalyzed by themammalianmembrane-bound or solubilized puriﬁed
complex I [23]. Also the kinetic mechanism of the NADH:HAR
reductase reaction is not a ping-pong type [23]. These facts strongly
suggest that some enzyme-bound redox component of complex I is
easily accessible for hydrophilic positively charged HAR (+3) when the
substrate binding “cleft” is occupied by the substrate (product)
nucleotide. This component is most likely ﬂavin because HAR is a
quite efﬁcient electron acceptor for FP which harbors only modiﬁed
low midpoint potential N-3 and N-1 iron–sulfur centers [20]. It would
be of great interest to see whether the T. thermophilus NDH-1
fragment is active in NADH:HAR reductase and, if so, what is the
kinetic mechanism of this reaction.
Interaction of NADHwith the intermediate 5 (equilibrium between
intermediates 5 and 6, Fig. 1) can be considered as true measure of
NADH afﬁnity to the reduced enzyme. The estimated value of K5 is
about 5·10−5 M which is close to the KiNADH in the energy-linked
reverse electron transfer reaction ((4–8)·10−5 M, Table 1) and to true
KS for NADH-reduced enzyme interaction determined by the more
direct approach (2·10−5 M, Table 2). These values when comparedwithTable 2





NADH (100)c 20b (50)c
NAD+ 800a (1000)c (7; 25)c
ADP-ribose 25 (30)c 400b
a Aerobically incubated coupled SMP in the presence of uncoupler.
b Complex I in coupled SMP reduced by the reverse electron transfer (coupled
succinate oxidation).
с Figures in brackets are representative values taken from Table 1.the upper limit for K1 (~1·10−4 M) as discussed above suggest that the
reduction of the enzyme (ﬂavin) increases its binding site afﬁnity to
NADH.
The lowest KmNADH (5·10−8 M half-saturating concentration) have
been reported for theNADH-supported superoxidegeneration catalyzed
by puriﬁed complex I in the presence of an NADH-regenerating system
[30]. This value can only be explained if superoxide productionproceeds
by a ping-pong mechanism exclusively via intermediates 1, 2, 3, 5with
extremely slow interconversion at step 5→1when oxygen serves as the
electron acceptor.
2.2. Binding of NAD+
NAD+ is a weak competitive inhibitor of NADH oxidation by either
natural (NADH oxidase) or artiﬁcial electron acceptors. KNAD
þ
i corre-
sponding toK4 in Fig.1 is (1–2)·10−3M, i.e. at least anorder ofmagnitude
higher than K1. It is also almost two orders of magnitude higher than
KNAD
þ
m in the energy-dependent reverse reactionwhich under “optimal”
conditions proceeds at the rate of approximately 1/5 of that of





i in the forward and reverse re-
actions in a framework of the scheme in Fig. 1 (with an assumption that
NAD+ reduction is a simple reversal of NADH oxidation) is to propose
that the energy-linked NAD+ reduction proceeds exclusively by ping-
pongmechanism, i.e. via intermediates 1, 5, 3, 2. It is worth emphasizing
that any apparent Km can be determined (from zero to inﬁnity) for a
ping-pong mechanism when maximal activity is varied by variation of
the second substrate concentration. The second substrate for the reverse
electron transfer is reduced ubiquinone and it is difﬁcult, if not
impossible, to design experimental conditions where the reductant,
QH2 could be varied at a constant level of pmf in order to verify the
kinetic mechanism of this reaction.
2.3. Binding of ADP-ribose
The only redox inactive competitive inhibitor of NADH oxidation by
complex I is ADP-ribose originally discovered as a contaminant in NAD+
samples [37]. The inhibitor shows a Ki of 3·10−5 M (mammalian
membrane-bound complex I) or 8·10−5 M (membrane-bound NDH-1 of
Paracoccus denitriﬁcans) [27], theafﬁnity to presumably oxidized enzyme
which is signiﬁcantly higher than that of NAD+. From the structural point
of view this suggests that the nicotinamide moiety of NAD+ does not
contribute to its binding afﬁnity (in fact weakens its primary binding).
Interestingly, ADP-ribose does not inhibit the energy-dependent reverse
electron transfer in coupled SMP or P. denitriﬁcans vesicles [26,37].
Moreover, the “inhibitor” increases the steady-state NADH/NAD+ ratio
reached when particles respire with succinate in the presence of low
concentration of NAD+ (aerobic reverse electron transfer) [37].
3. Nucleotide binding without enzyme turnover
As it is evident from the “minimal” kinetic scheme (Fig. 1) the
interactions of nucleotides with complex I during the steady-state
turnover give rise to at least six intermediates and depending on the
particular pathwayand speciﬁc activity the equilibriumconstantsK1−K5
may or may not be signiﬁcantly inﬂuenced by the kinetic terms, such as
the rate constants for irreversible steps (kcat's). It seemeddesirable to use
other approaches which would allow determination of true binding
constants for nucleotides under equilibrium conditions. The protective
effect of the substrate (product) against the binding site-directed
irreversible inhibitor is the method widely used for this purpose. Until
recently no such inhibitor for complex I was available. In 2005 Kotlyar et
al. reported that prolonged incubation of NADH under alkaline aerobic
conditions results in a formation of an NADH derivative (operationally
named NADH-OH) which speciﬁcally interacts with complex I or FP in
close to 1:1 stoichiometric ratio [38]. Although the exact chemical
Fig. 2. Reversible dissociation of FMN from themembrane-bound complex I. SMPwere
preincubated for 1 h at pH 10, 20 °C. The additions: 1, none (control); 2, 100 μMNADH;
3,100 μMNADHand 1mMNAD+; 4,100 μMNADH and 10 μMFMN; 5,10 μMFMNadded
after inactivation (sample 2) has been completed.
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be a very useful tool for several aspects of complex I studies particularly
for evaluation of NADH/NAD+ binding parameters. A short summary of
these studies [39] are shown in Table 2 and brieﬂy discussed below.
Reduction of the enzyme (by succinate and pmf) results in signiﬁcant
(~10 times) decrease of NADH-OH reactivity towards its binding site.
Under the conditionswhere NADH-OH interactswith the enzyme in the
ﬁrst-order fashion NAD+, NADH and ADP-ribose fully protect complex I
against irreversible inhibition and their binding constants thus
determined are redox-dependent (Table 2). The representative ﬁgures
for correspondingK's derived from the steady-state kinetics (Table 1) are
given in brackets for comparison. The data shown inTable 2 suggest that
binding of nucleotides per se alters the redox potential of the enzyme
(ﬂavin) shifting it to lower Em value (note the more than 10 times
difference in the binding constants of redox inactive ADP-ribose to the
reduced and oxidized enzyme).
Another interesting fact of NADH-OH interaction is the non-trivial
inhibitionpattern observedwhen forward (NADHoxidase) and reverse
(succinate-supported NAD+ reduction) are assayed after preincubation
of SMPwith gradually increasing concentrations of the inhibitor. NADH
oxidase titration appears as a straight line with the ﬁnal titration point
similar to that for piericidin (~0.1 nmol/mg of protein [27]). In contrast,
titration of the energy-linked NAD+ reduction appears as a curve with
substantial lag in inhibition and the same ﬁnal titration point. In other
words, a region exists where NAD+ reduction is not inhibited whereas
NADH oxidation is substantially decreased.
Several reasons for this type of titration merit consideration. It is
conceivable that the potential activity of complex I in the reverse reaction
(NAD+ reduction) greatly exceeds the pmf-generating capacity of
succinate oxidase. This model if considered as two homogeneous
enzymes: QH2 (and pmf)-producing and QH2 (and pmf)-utilizing system,
would result in the convex titration curve as observed. However, since
pmf is involved as an intermediate, operation of succinate oxidase and
coupled complex I-mediated NAD+ reductase should be regarded as a
gearwheel transmission and the rate-limiting enzymemodel seemshard
to apply. Another possible explanation is that the catalytic activity of
complex I in the reverse direction increases as the driving force (pmf)
increases. In other words the turnover number of the residual, not
inhibited complex I increases upon decrease of the load in the
electrochemically coupled unit thus resulting in pmf increase. Such a
model has been suggested for different “modality” of Fo·F1 operation in
ATP synthesis [40,41]. Both, rate-limit and different “modality” models
predict that any “irreversible” inhibitor of complex I would give convex
titration curves for reverse electron transfer which is, however, not the
case for example, for piericidin [27]. A modiﬁed model with two
cooperative nucleotide binding sites [35] could explain the non-trivial
titrationpattern.A twonucleotidebinding sitemodeldoesnotnecessarily
contradict the atomic structure of hydrophilic fragment of T. thermophilus
NDH-1 [36] where a single tunnel to deeply buried FMN is seen.
4. Redox-dependent ﬂavin–protein interaction
Redox-dependency of nucleotide afﬁnity to the enzyme active sites
suggests that conformations of the reduced and oxidized protein are
different at least in the area where primary binding of the nucleotides
takes place. Several observations point to FMN, the primary oxidant
[42,43] as the component responsible (involved) for structural
rearrangements that occur upon its oxidoreduction. Tightly bound
FMN located in 51 kDa (Nqo-1) subunit is not covalently bound [44]
and oxidoreduction of the isoalloxazine ring is expected to change its
binding afﬁnity to the protein. This phenomenon is well documented
for a number of otherﬂavoproteins (see, for example Refs. [45,46]). The
ﬁrst direct evidence for the redox-dependent change of FMN binding
afﬁnity operationally called “reductive inactivation” has been reported
for the hydrophilic three-subunits FP [47]. When diluted samples of FP
were incubated with NADH or dithionite the catalytic activity(menadione reductase) gradually decreased due to FMN dissociation.
The enzymewas protected againstNADH-induced inactivation by FMN
and (or) NAD+. The midpoint FMN potential of −325 mV (pH 8.0) was
estimated from the dependency of inactivation rate on NADH/NAD+
ratio. The reductant-induced inactivation was irreversible thus
suggesting that in addition to its redox cofactor function FMN plays
an important role in maintaining a stable conformation of FP. These
ﬁndings together with data on the redox-dependent nucleotide
afﬁnity change [39] prompted us to search for conditions where re-
versible dissociation of FMN could be demonstrated in a systemwhere
theﬂavin bindingNqo-1 subunit is in close contactwith other subunits
within native membrane-bound complex I. Recently we were able to
demonstrate the reversible dissociation of FMN from complex I as
illustrated in Fig. 2. Three factors happen to be of crucial importance for
reversible dissociation of FMN: strong dilution of the enzyme samples
(expected from Ostwald's dilution law), alkaline pH, and the presence
of NADH. The NADH-induced inactivation is seen for both rotenone-
insensitive HAR reductase and rotenone-sensitive Q1 reductase
activities, and either activity is protected and speciﬁcally restored by
FMN. Remarkably, the rate of NADH-induced FMN dissociation is not
diminished at high NADH concentration, i.e. under the conditions
where the “tunnel” leading to buried FMN (according to the atomic
structure of T. thermophilus NDH-1 fragment [36]) is expected to be
occupied by NADH. This observation points to an existence of an “other
door” for FMNH− dissociation different from the cleft where ferricyanide
and NADH compete for accessibility to the ﬂavin (see previous sections).
The data described above can be brieﬂy and somehow hypothetically
summarized as follows. (i) Binding of FMN to the 51 kDa subunit within
complex I signiﬁcantly shifts its midpoint redox potential compared to
the free FMN/FMNH− couple [48] to the negative side (see also Refs. [34]
and [30] for Em values of FMN/FMNH− couple in complex I as emerged
from ﬂavin semiquinone EPR studies and from the data on superoxide
generation, respectively). (ii) The reduction of FMN results in weakened
binding which may lead to its dislocation within the binding cavity
coupled with conformational change of the protein. (iii) Accessibility of
the ﬂavin for hydrophilic substances including artiﬁcial electron
acceptors and nucleotides seems to be dynamic and changes upon
FMN oxidoreduction during enzyme turnover.
5. Concluding remarks
After brief discussion of the kinetic and equilibrium studies on
NADH/NAD+ interactions with complex I natural question arises: does
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(NAD+) oxidation (reduction) by complex I? It is doubtful that we can
answer this question with our present state of knowledge. Some
kinetic data substantiated by more direct quantitation of binding
constants in the absence of the enzyme turnover (Table 2) agree with
the scheme. The others, such as the unidirectional effect of ADP-
ribose on forward and reverse electron transfer [26,37], peculiar
titration of NADH oxidation and NAD+ reduction by the site-directed
inhibitor, signiﬁcant apparent discrepancy between only weak
inhibitory effect of NAD+ on NADH oxidation and low KNAD
þ
m in
reverse electron transfer are difﬁcult to explain within this deliber-
ately simpliﬁed scheme. The two nucleotide binding site model [35]
which has been suggested for mammalian complex I to overcome
these difﬁculties received no support from the structural data on T.
thermophilusNDH-1 [36]. It is pertinent to emphasize that this model
was originated from kinetic studies and the key question which
should be answered to accept or discharge it is whether catalytically
competent complex exists that contains two simultaneously bound
nucleotides at two or single site(s) during catalysis of any particular
reaction. It should also be noted that the two-sitemodelwas based on
data obtained for a system where complex I operates as an intrinsic
component of themitochondrial respiratory chain andwhere natural
heterogeneity of complex I within the inner mitochondrial mem-
brane seems likely to exist. This heterogeneity may arise from the
permanent or rapidly equilibrating interaction of a monomer–dimer
complex I entity or from complex I–complex III [49] and/or complex
I–complex II temporary or stable associations. The possibility that
these interactions would affect the nucleotide binding properties of
complex I cannot be excluded.
Most of the kinetic data relevant to the nucleotide binding re-
ported in the literature have been obtained for the preparations
incapable of the major enzyme function, i.e. that is energy transduc-
tion. On the other hand, binding and dissociation of NADH/NAD+
coupled with FMN redox potential alteration accompanied by
conformational change of the protein may be an essential energetic
contributor to the overall proton-translocating mechanism. Detailed
studies on nucleotide binding parameters for complex I operating as
an energy-coupled device are evidently needed. Particularly, energy-
linked reverse electron transfer, the reaction discovered almost ﬁfty
years ago [50] is still only superﬁcially understood in terms of its
kinetic parameters. Whether complex I operates in the forward and
reverse directions via a series of the same intermediates (micro-
reversibility principle) or the energy-transducing NADH:ubiquinone
reductase and ubiquinol:NAD+ reductase activities are catalyzed by
rapidly or slowly equilibrating “isoforms” of complex I is an open
question. In my opinion, which was advocated for another energy-
transducing enzyme, Fo·F1-ATP synthase [51], complex I is a macro-
molecular electro-mechano-chemical machine and as any other man-
made or nature-created machine it operates in forward and reverse
directions in different modes.
The ﬁnal note concerns the signiﬁcance of the kinetic studies of
complex I. The next step following recent breakthroughs in the ﬁeld,
i.e. X-ray resolution of T. thermophilusNDH-1 fragment [36], resolution
of the atomic structures of complete prokaryotic and eukaryotic
complexes is expected. However valuable the knowledge of these
static structures are, they will not reveal dynamic interactions
between the subunits during catalysis. To understand how a machine
works we need to see it at work. For enzymes work is their turnover.
Thus, quantitative studies of the enzyme turnover, i.e. enzyme kinetics
were, are, and continue to be a powerful tool for bioenergetics.
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